What does Inositol do?

Natural compound shown to improve insulin sensitivity, support PCOS, and reduce pregnancy complications.

Most clinical trials in the provided studies are small pilot studies (30–60 participants), limiting confidence in effect sizes

Inositol - Science-Based Research

What the Science Says

Inositol is a naturally occurring sugar alcohol found in the body that acts as a cellular messenger, helping regulate insulin signaling and hormone balance. Clinical trials show it can improve insulin resistance in women with PCOS, reduce markers of metabolic dysfunction, and lower the risk of preterm birth and preeclampsia in overweight or obese pregnant women. Studies used doses of 2000 mg twice daily, typically over 6–16 weeks, with measurable effects on blood sugar markers and reproductive outcomes.

What It Doesn't Do

Not a proven treatment for thyroid cancer on its own — the thyroid research is still in early pilot stages. Won't replace metformin for diabetes management. No strong evidence it improves general fertility in women without PCOS. The liver-protection and fatty liver benefits are from animal studies only — not proven in humans yet.

Evidence-Based Benefits

Inositol is a naturally occurring sugar alcohol found in the body that acts as a cellular messenger, helping regulate insulin signaling and hormone balance. Clinical trials show it can improve insulin resistance in women with PCOS, reduce markers of metabolic dysfunction, and lower the risk of preterm birth and preeclampsia in overweight or obese pregnant women. Studies used doses of 2000 mg twice daily, typically over 6–16 weeks, with measurable effects on blood sugar markers and reproductive outcomes.

Moderate Evidence

Effective at: 2000-4000 mg daily based on study doses

Source: auto-research

Absorption & Bioavailability

Good — myo-inositol is well absorbed orally and is naturally synthesized in the body; pharmacokinetic data from preclinical models suggests efficient tissue distribution, though human pharmacokinetic studies are limited in the provided papers

Red Flags to Watch For

Most clinical trials in the provided studies are small pilot studies (30–60 participants), limiting confidence in effect sizes
Combining myo-inositol with metformin or other insulin-sensitizing drugs without medical supervision may cause additive blood sugar lowering
Thyroid cancer application (re-differentiation therapy) is experimental and should not be self-administered
Probiotic co-supplementation in pregnancy was associated with increased preterm birth risk in the same meta-analysis — be cautious about stacking supplements during pregnancy